510(k) Report

510(k) · Cleared

Cleared

Well-Pex

K080266510(k) TraditionalCleared Feb 6, 20085-day reviewClass II21 CFR 872.3820

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vericom Co., Ltd. · KIF Resin, Root Canal Filling

Cleared on Feb 6, 2008 as substantially equivalent to K032603 (Meta Biomed Co., Ltd., 2003) after a 5-day review. Its family tree reaches back 2 generations to 1997.

Decided
Feb 6, 2008
Review
5 days
Class
Class II
Product code
KIF
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K973667 (1997). No later device cites it as a predicate yet.

  1. Root · 2 generations backK973667 Vitapex Pre-Loaded Dental SyringeNeodental Chemical Products Co., Ltd. · 1997
  2. 1 generation backK032603 Metapex Calcium Hydroxide with Lodoform Temporary Root Canal FillingMeta Biomed Co., Ltd. · 2003
  3. This deviceK080266 Well-PexVericom Co., Ltd. · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K973667Vitapex Pre-Loaded Dental SyringeNeodental Chemical Products Co., Ltd.1997—
−1K032603Metapex Calcium Hydroxide with Lodoform Temporary Root Canal FillingMeta Biomed Co., Ltd.2003—
0 (this device)K080266Well-PexVericom Co., Ltd.2008—
FIG. 1 — Lineage of K080266, 1997–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KIF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KIF device

  1. #1 K250710 Injectable Root Canal Bioceramic Sealer (nRoot…score 14.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032603Metapex Calcium Hydroxide with Lodoform Temporary Root Canal Filling
Summary page 1
…x~h Common Name - Root canal filling Materials Classification Name - Resin, Root Canal Filing 3. Predicate Device Metapex, META BIOMED CO. LTD. K032603 4. Description Well-PexrM is a temporary root canal filling material after pulpectomy, or for apexogenesis or ape…
Meta Biomed Co., Ltd.2003—

Also cleared against K032603: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 3 companies; a new generation was cleared every 5.9 years on median.
  • None of the 2 ancestors has a recall.
  • 3 other devices also cite its predicate K032603.

How does its category compare?

All KIF devices

KIF Resin, Root Canal Filling: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · KIF

7in 2025

2007: 22008: 42009: 52010: 52012: 52013: 22014: 102015: 12016: 52017: 32018: 52019: 72020: 32021: 122022: 32023: 72024: 82025: 72026 (partial year): 7
2007high 12 (2021) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KIF

90in 2025

2008: 31 days median2009: 94 days median2010: 75 days median2012: 172 days median2014: 220 days median2016: 212 days median2017: 211 days median2018: 147 days median2019: 252 days median2020: 239 days median2021: 89 days median2022: 152 days median2023: 59 days median2024: 96 days median2025: 90 days median2026 (partial year): 108 days median
2007high 252 (2019) · low 31 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KIF

1in 2009

2009: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KIF

55in 2025

2008: 22009: 72010: 102011: 82012: 42013: 792014: 4212015: 152016: 52017: 52018: 132019: 62020: 32021: 92022: 102023: 72024: 102025: 55
2007high 421 (2014) · low 0 (2007)2025

MAUDE reports naming product code KIF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
200843102
200959417
2010575010
20110—08
2012517204
20132—079
2014102200421
20151—015
2016521205
2017321105
20185147013
2019725206
2020323903
2021128909
20223152010
202375907
2024896010
2025790055
202671080—

What is it indicated for?

Well-Pex T is a biocompatible temporary or permanent root canal sealer, for use to stimulate healing process due to the mixture of calcium hydroxide and iodoform and the induction effect of these two ingredients. Used to promote healing effects and to help prevent bacterial contamination of the canal, as the two ingredients improve the induction effect for hard tissue induction and deposition. To be used as a medicament for the treatment of infected mot…

Read the full statement (145 words)

Well-Pex T is a biocompatible temporary or permanent root canal sealer, for use to stimulate healing process due to the mixture of calcium hydroxide and iodoform and the induction effect of these two ingredients. Used to promote healing effects and to help prevent bacterial contamination of the canal, as the two ingredients improve the induction effect for hard tissue induction and deposition. To be used as a medicament for the treatment of infected mot canals and as a permanent, low volume additive to the filling process of a treated root canal to assist in the induction and deposition of hard tissue to make the healing process more rapid and complete. For use in the treatment of infected mot canals, or following pulpectomy, or for apexegenesis or apexification, and/or for the tip filling of prepared, treated root canals at the time of final filling with gutta-percha.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K080266: Well-Pex.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K080266

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026